The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kamal Mostafa since 2017.
This trader's CIK number is 1647234.
At the time of last reporting, Kamal Mostafa was the CEO, Magellan Rx Management of Magellan Health Inc. (stock ticker symbol MGLN).
Also see all insider trading activities at Magellan Health Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | MGLN | 0 | $0 | 0 | $0 | 6,242 | $0 |
| 2020 | MGLN | 0 | $0 | 36,884 | $3,059,128 | 4,365 | $0 |
| 2019 | MGLN | 0 | $0 | 16,766 | $1,319,735 | 3,996 | $0 |
| 2018 | MGLN | 0 | $0 | 17,094 | $1,704,902 | 902 | $0 |
| 2017 | MGLN | 0 | $0 | 39,330 | $3,348,576 | 319 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-04 | MGLN | Option Ex | 6,242 | .00 | 0 |
| 2020-12-09 | MGLN | Sale | 2,793 | 79.69 | 222,574 |
| 2020-11-13 | MGLN | Sale | 13,282 | 83.82 | 1,113,323 |
| 2020-11-16 | MGLN | Sale | 7,603 | 86.57 | 658,191 |
| 2020-11-10 | MGLN | Sale | 6,000 | 81.57 | 489,419 |
| 2020-11-05 | MGLN | Sale | 3,589 | 79.87 | 286,653 |
| 2020-11-04 | MGLN | Sale | 3,434 | 79.89 | 274,352 |
| 2020-10-16 | MGLN | Sale | 183 | 79.87 | 14,616 |
| 2020-03-03 | MGLN | Option Ex | 4,365 | .00 | 0 |
| 2019-12-09 | MGLN | Sale | 16,766 | 78.72 | 1,319,735 |
| 2019-03-03 | MGLN | Option Ex | 3,996 | .00 | 0 |
| 2018-04-02 | MGLN | Sale | 1,666 | 106.20 | 176,929 |
| 2018-03-07 | MGLN | Option Ex | 727 | .00 | 0 |
| 2018-03-04 | MGLN | Option Ex | 175 | .00 | 0 |
| 2018-03-05 | MGLN | Sale | 15,428 | 99.04 | 1,527,973 |
| 2017-12-04 | MGLN | Sale | 2,180 | 92.00 | 200,560 |
| 2017-11-01 | MGLN | Sale | 1,154 | 92.00 | 106,168 |
| 2017-09-28 | MGLN | Sale | 4,848 | 85.76 | 415,783 |
| 2017-09-27 | MGLN | Sale | 19,126 | 85.68 | 1,638,753 |
| 2017-09-15 | MGLN | Sale | 2,961 | 84.00 | 248,724 |
| 2017-09-13 | MGLN | Sale | 585 | 83.00 | 48,555 |
| 2017-09-12 | MGLN | Sale | 19 | 83.00 | 1,577 |
| 2017-09-08 | MGLN | Sale | 6,267 | 81.53 | 510,917 |
| 2017-09-05 | MGLN | Sale | 1,157 | 80.96 | 93,669 |
| 2017-09-07 | MGLN | Sale | 1,033 | 81.19 | 83,870 |
| 2017-03-05 | MGLN | Option Ex | 144 | .00 | 0 |
| 2017-03-04 | MGLN | Option Ex | 175 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kamal Mostafa (CEO, Magellan Rx Management of Magellan Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.